🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,99 USD

Máx. histórico

178,74

2143 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,38%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+2,43%

Cierre anterior

18,54

Rango de hoy

18,52 – 19,26

Volumen hoy

1.328.200

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 1 día
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/08/2022 111,01 111,94 109,52 110,28 -1,44% 2,18% 606.500
26/08/2022 113,90 114,02 110,66 111,89 -1,69% 2,95% 813.800
25/08/2022 115,29 116,91 113,35 113,81 -0,82% 3,09% 878.300
24/08/2022 108,74 116,63 108,29 114,75 +5,19% 7,67% 1.775.300
23/08/2022 107,85 110,01 106,02 109,09 +1,26% 3,70% 892.900
22/08/2022 108,19 111,48 107,42 107,73 -0,12% 3,75% 873.000
19/08/2022 108,31 109,11 106,93 107,86 -0,73% 2,01% 774.400
18/08/2022 109,00 109,15 106,14 108,65 -0,32% 2,76% 573.100
17/08/2022 107,33 110,33 106,83 109,00 +1,09% 3,26% 847.500
16/08/2022 109,25 109,50 106,75 107,83 -1,11% 2,52% 1.127.200
15/08/2022 108,16 109,37 107,40 109,04 +0,04% 1,82% 1.243.900
12/08/2022 109,30 110,96 108,61 109,00 -0,24% 2,15% 1.028.700
11/08/2022 112,31 113,42 108,69 109,26 -3,37% 4,21% 1.022.200
10/08/2022 109,31 113,60 109,31 113,07 +3,64% 3,92% 1.014.300
09/08/2022 112,46 112,89 107,75 109,10 -2,13% 4,57% 1.999.600
08/08/2022 105,95 111,90 105,45 111,47 +5,14% 6,09% 2.183.700
05/08/2022 100,60 107,03 99,45 106,02 +4,50% 7,53% 1.407.700
04/08/2022 96,20 103,16 96,19 101,45 +5,56% 7,25% 1.599.100
03/08/2022 94,34 96,23 92,54 96,11 +2,23% 3,91% 2.391.900
02/08/2022 91,35 94,71 90,95 94,01 +2,69% 4,12% 1.143.400
01/08/2022 92,76 93,92 90,40 91,55 -1,51% 3,79% 829.100
29/07/2022 96,02 96,02 89,75 92,95 +8,17% 6,53% 3.663.800
28/07/2022 86,52 86,52 84,05 85,93 +0,08% 2,85% 379.300
27/07/2022 82,83 86,28 82,48 85,86 +4,02% 4,59% 677.400
26/07/2022 82,87 84,36 81,26 82,54 -0,79% 3,74% 561.100
25/07/2022 83,61 84,26 82,10 83,20 -0,94% 2,58% 422.100
22/07/2022 85,19 85,31 83,80 83,99 -0,79% 1,77% 572.000
21/07/2022 85,62 85,91 84,11 84,66 -0,92% 2,10% 461.100
20/07/2022 84,73 86,40 84,01 85,45 +0,89% 2,82% 412.600
19/07/2022 84,75 85,94 84,04 84,70 +0,32% 2,24% 661.500